Study with ASO targeting ANGPTL3 mRNA highlights importance of rigorous evaluation of new therapies
This video was recorded at the Congress of the American College of Cardiology (ACC) 2022.
Brian Bergmark, MD is an Associate Physician in Interventional Cardiology in the Division of Cardiovascular Medicine at the Brigham and Women's Hospital, Boston, MA, USA.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: